Synthesis and characterization of a high-affinity {alpha}v{beta}6-specific ligand for in vitro and in vivo applications.
about
Molecular imaging of integrin αvβ6 expression in living subjects.A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or densityCombinatorial peptide libraries: mining for cell-binding peptides.MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells.Dimerization of a phage-display selected peptide for imaging of αvβ6- integrin: two approaches to the multivalent effect.Development of homomultimers and heteromultimers of lung cancer-specific peptoids.Identification of a novel lysosomal trafficking peptide using phage display biopanning coupled with endocytic selection pressureChemoselective tarantula toxins report voltage activation of wild-type ion channels in live cellsFrom phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarkerEvaluation of phage display discovered peptides as ligands for prostate-specific membrane antigen (PSMA).Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer.Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin αvβ₆Tumor-targeting peptides from combinatorial libraries.Multifunctional αvβ6 Integrin-Specific Peptide-Pt(IV) Conjugates for Cancer Cell Targeting.Exploring the Role of RGD-Recognizing Integrins in Cancer.Dissecting the binding mode of low affinity phage display peptide ligands to protein targets by hydrogen/deuterium exchange coupled to mass spectrometry.Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models.
P2860
Q27007536-57E041F9-12CC-4439-B5CF-D2BB34300D39Q27308658-7B1F12A2-569F-462E-AEE6-7BBEEFE380C8Q31144876-38CA4084-4974-436A-84DA-FD53C888F7B8Q33496895-F4222049-C1A5-4DA2-A1DA-36ED05E88996Q33686825-9BDA6F7B-1258-4624-998D-BA0968501EBCQ34105317-CDE74980-5EF7-486E-8880-47FF26708AEFQ34343508-2E438121-61B6-4A65-BF8F-BFAA6037948DQ34480591-C3C807F3-D41D-434D-9AE4-D23D018696A8Q34491680-2E891DC6-A36F-40F1-A6A1-04D8AC7F8FE0Q34918072-4F6D0083-4339-42A1-B7C7-FA6AD540BD7EQ35131992-793DBCD1-A5D0-45D3-A3DC-1173612C7529Q35368323-B2892E6D-5FAF-462B-A4DA-2B1B7AE6C5A9Q36025723-A7FB8932-F6CD-4085-A746-EF1A4A0114C3Q38695235-49BE9715-E8AF-4178-8F23-5C4ADC82FE7EQ41670915-7F1F3711-CD3A-43C3-86BE-7626B41BFD7FQ41876518-D60EF312-3385-4939-8D15-532CFCB88220Q48315576-3AD3AD5A-6420-40C7-8272-602CEB165EB8
P2860
Synthesis and characterization of a high-affinity {alpha}v{beta}6-specific ligand for in vitro and in vivo applications.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Synthesis and characterization ...... itro and in vivo applications.
@ast
Synthesis and characterization ...... itro and in vivo applications.
@en
type
label
Synthesis and characterization ...... itro and in vivo applications.
@ast
Synthesis and characterization ...... itro and in vivo applications.
@en
prefLabel
Synthesis and characterization ...... itro and in vivo applications.
@ast
Synthesis and characterization ...... itro and in vivo applications.
@en
P2093
P2860
P1476
Synthesis and characterization ...... itro and in vivo applications.
@en
P2093
Kathlynn C Brown
Michael J McGuire
Tsukasa Oyama
Xiankai Sun
Ying-Horng Liu
P2860
P304
P356
10.1158/1535-7163.MCT-08-1098
P577
2009-05-12T00:00:00Z